Europe — EMA
Palmeux (Paliperidone Palmitate)
Paliperidone palmitate, the active ingredient in Palme de, is a atypical antipsychotic presented as a long‑acting injectable suspension for intramuscular use.
Request sourcing
What is Paliperidone Palmitate?
Paliperidone palmitate, the active ingredient in Palme de, is a atypical antipsychotic presented as a long‑acting injectable suspension for intramuscular use. It is indicated for the treatment of schizophrenia in adult patients. GNH USA supplies Palmeux as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Palmeux as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Paliperidone Palmitate used for?
Palmeux is a long‑acting antipsychotic that modulates dopamine pathways in schizophrenia management.
- Schizophrenia: Improves symptom control and reduces risk of relapse. - Schizoaffective disorder: Helps stabilise mood and psychotic symptoms. - Bipolar I disorder (adjunctive): May reduce acute manic episodes. - Maintenance therapy: Supports long‑term adherence by monthly dosing.
What are the side effects of Paliperidone Palmitate?
Common Side Effects: - - t t t \n Serious or t ewline ewline ewline ewline ewline ewline ewline
